BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, Ren D, Hua Y, Yu B, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Xiong W, Zeng Z. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer 2021;20:7. [PMID: 33397409 DOI: 10.1186/s12943-020-01288-1] [Cited by in Crossref: 59] [Cited by in F6Publishing: 75] [Article Influence: 29.5] [Reference Citation Analysis]
Number Citing Articles
1 Inukai K, Kise K, Hayashi Y, Jia W, Muramatsu F, Okamoto N, Konishi H, Akuta K, Kidoya H, Takakura N. Cancer apelin receptor suppresses vascular mimicry in malignant melanoma. Pathol Oncol Res 2023;29. [DOI: 10.3389/pore.2023.1610867] [Reference Citation Analysis]
2 Lin K, Huang L, Zhang Y, Chen M, Li Z, Yung KKL, Lv S, Pan Q, Zhang W, Fu J, Li W, Deng Q. The Antiangiogenic and Antitumor Effects of Scoparasin B in Non-Small-Cell Lung Cancer. J Nat Prod 2023. [PMID: 36692021 DOI: 10.1021/acs.jnatprod.2c00979] [Reference Citation Analysis]
3 Xu W, Yang S, Lu L, Xu Q, Wu S, Zhou J, Lu J, Fan X, Meng N, Ding Y, Zheng X, Lu W. Influence of lung cancer model characteristics on tumor targeting behavior of nanodrugs. J Control Release 2023;354:538-53. [PMID: 36641120 DOI: 10.1016/j.jconrel.2023.01.026] [Reference Citation Analysis]
4 Sun R, Yuan L, Jiang Y, Wan Y, Ma X, Yang J, Sun G, Zhou S, Wang H, Qiu J, Zhang L, Cheng W. ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer. Theranostics 2023;13:833-48. [PMID: 36632222 DOI: 10.7150/thno.77441] [Reference Citation Analysis]
5 Karavasili K, Koolwijk P. Hypoxia: A Potent Regulator of Angiogenesis Through Extracellular Matrix Remodelling. Matrix Pathobiology and Angiogenesis 2023. [DOI: 10.1007/978-3-031-19616-4_8] [Reference Citation Analysis]
6 Kim Y, Danaher P, Cimino PJ, Hurth K, Warren S, Glod J, Beechem JM, Zada G, Mceachron TA. Highly Multiplexed Spatially Resolved Proteomic and Transcriptional Profiling of the Glioblastoma Microenvironment Using Archived Formalin-Fixed Paraffin-Embedded Specimens. Modern Pathology 2023;36:100034. [DOI: 10.1016/j.modpat.2022.100034] [Reference Citation Analysis]
7 Cheng Y, Chen Q, Qian Z, Shan T, Bai L, Jiang X, Li C, Wang Y. Versatile Red Blood Cells for Triple-Negative Breast Cancer Treatment via Stepwise Photoactivations. Adv Healthc Mater 2023;12:e2201690. [PMID: 36263794 DOI: 10.1002/adhm.202201690] [Reference Citation Analysis]
8 Wang Q, Wang K, Tan X, Li Z, Wang H. Immunomodulatory role of metalloproteases in cancers: Current progress and future trends. Front Immunol 2022;13:1064033. [PMID: 36591235 DOI: 10.3389/fimmu.2022.1064033] [Reference Citation Analysis]
9 Guo J, Xing W, Liu W, Liu J, Zhang J, Pang Z. Prognostic value and risk model construction of hypoxic stress-related features in predicting gastric cancer. Am J Transl Res 2022;14:8599-610. [PMID: 36628224] [Reference Citation Analysis]
10 Cheng T, Zhang S, Xia T, Zhang Y, Ji Y, Pan S, Xie H, Ren Q, You Y, You B. EBV promotes vascular mimicry of dormant cancer cells by potentiating stemness and EMT. Exp Cell Res 2022;421:113403. [PMID: 36336028 DOI: 10.1016/j.yexcr.2022.113403] [Reference Citation Analysis]
11 Siminzar P, Tohidkia MR, Eppard E, Vahidfar N, Tarighatnia A, Aghanejad A. Recent Trends in Diagnostic Biomarkers of Tumor Microenvironment. Mol Imaging Biol 2022. [DOI: 10.1007/s11307-022-01795-1] [Reference Citation Analysis]
12 Hargadon KM, Goodloe TB 3rd, Lloyd ND. Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective. Cancer Metastasis Rev 2022;41:833-52. [PMID: 35701636 DOI: 10.1007/s10555-022-10045-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang J, Xia W, Huang Y, Li H, Tang Y, Li Y, Yi B, Zhang Z, Yang J, Cao Z, Zhou J. A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer. Front Immunol 2022;13:1016612. [PMID: 36505458 DOI: 10.3389/fimmu.2022.1016612] [Reference Citation Analysis]
14 Cui M, Liu Y, Cheng L, Li T, Deng Y, Liu D. Research progress on anti-ovarian cancer mechanism of miRNA regulating tumor microenvironment. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1050917] [Reference Citation Analysis]
15 Kim YK, Hong Y, Bae YR, Goo J, Kim SA, Choi Y, Nam G, Kwon M, Yun SG, Lee G, Jeong C, Kim I. Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy. Journal of Controlled Release 2022;351:727-738. [DOI: 10.1016/j.jconrel.2022.09.042] [Reference Citation Analysis]
16 Tang J, Wu Z, Wang X, Hou Y, Bai Y, Tian Y. Hypoxia-Regulated lncRNA USP2-AS1 Drives Head and Neck Squamous Cell Carcinoma Progression. Cells 2022;11:3407. [DOI: 10.3390/cells11213407] [Reference Citation Analysis]
17 Qin R, Zhao H, He Q, Li F, Li Y, Zhao H. Advances in single-cell sequencing technology in the field of hepatocellular carcinoma. Front Genet 2022;13:996890. [DOI: 10.3389/fgene.2022.996890] [Reference Citation Analysis]
18 Zhang Y, Ji J, Wang J, Wang Y, Zhu H, Sun R, Liu Q, Chen X. The Role of N6-Methyladenosine Modification in Microvascular Dysfunction. Cells 2022;11:3193. [DOI: 10.3390/cells11203193] [Reference Citation Analysis]
19 Shi F, Wu J, Jia Q, Li K, Li W, Shi Y, Wang Y, Wu S. Relationship between the expression of ARHGAP25 and RhoA in non-small cell lung cancer and vasculogenic mimicry. BMC Pulm Med 2022;22:377. [PMID: 36207695 DOI: 10.1186/s12890-022-02179-5] [Reference Citation Analysis]
20 Wang Y, Wang D, Zhang Y, Xu H, Shen L, Cheng J, Xu X, Tan H, Chen X, Li J. Tumor Microenvironment-Adaptive Nanoplatform Synergistically Enhances Cascaded Chemodynamic Therapy. Bioact Mater 2023;22:239-53. [PMID: 36254272 DOI: 10.1016/j.bioactmat.2022.09.025] [Reference Citation Analysis]
21 Giusti I, Poppa G, D’ascenzo S, Esposito L, Vitale AR, Calvisi G, Dolo V. Cancer Three-Dimensional Spheroids Mimic In Vivo Tumor Features, Displaying “Inner” Extracellular Vesicles and Vasculogenic Mimicry. IJMS 2022;23:11782. [DOI: 10.3390/ijms231911782] [Reference Citation Analysis]
22 Luo Y, Yang Z, Yu Y, Zhang P. HIF1α lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.10.014] [Reference Citation Analysis]
23 Barcellini A, Fontana G, Maria Filippini D, Ronchi S, Bonora M, Vischioni B, Ingargiola R, Maria Camarda A, Loap P, Facchinetti N, Licitra L, Baroni G, Orlandi E. Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy. Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2022.10.027] [Reference Citation Analysis]
24 Zhao N, Chen C, Guo Y, Liu T, Che N, Zhang D, Liang X, Zhang Y, Zhao X. LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry. Dig Liver Dis 2022:S1590-8658(22)00695-8. [PMID: 36192339 DOI: 10.1016/j.dld.2022.09.003] [Reference Citation Analysis]
25 Cheng W, Xiao X, Liao Y, Cao Q, Wang C, Li X, Jia Y. Conducive target range of breast cancer: Hypoxic tumor microenvironment. Front Oncol 2022;12:978276. [DOI: 10.3389/fonc.2022.978276] [Reference Citation Analysis]
26 Johnson AL, Laterra J, Lopez-bertoni H. Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities. Front Oncol 2022;12:995498. [DOI: 10.3389/fonc.2022.995498] [Reference Citation Analysis]
27 García-caballero M, Sokol L, Cuypers A, Carmeliet P. Metabolic Reprogramming in Tumor Endothelial Cells. IJMS 2022;23:11052. [DOI: 10.3390/ijms231911052] [Reference Citation Analysis]
28 Han H, Lee S, Xu Y, Kim J, Lee H. SPHK/HIF-1α Signaling Pathway Has a Critical Role in Chrysin-Induced Anticancer Activity in Hypoxia-Induced PC-3 Cells. Cells 2022;11:2787. [DOI: 10.3390/cells11182787] [Reference Citation Analysis]
29 Sanati M, Afshari AR, Amini J, Mollazadeh H, Jamialahmadi T, Sahebkar A. Targeting angiogenesis in gliomas: Potential role of phytochemicals. Journal of Functional Foods 2022;96:105192. [DOI: 10.1016/j.jff.2022.105192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Li X, Peng X, Zhang C, Bai X, Li Y, Chen G, Guo H, He W, Zhou X, Gou X. Bladder Cancer-Derived Small Extracellular Vesicles Promote Tumor Angiogenesis by Inducing HBP-Related Metabolic Reprogramming and SerRS O-GlcNAcylation in Endothelial Cells. Adv Sci (Weinh) 2022;:e2202993. [PMID: 36045101 DOI: 10.1002/advs.202202993] [Reference Citation Analysis]
31 Bhattacharya S. Metabolic Reprogramming and Cancer: 2022. Qeios 2022. [DOI: 10.32388/ck9vjb.3] [Reference Citation Analysis]
32 Luo X, Zou W, Wei Z, Yu S, Zhao Y, Wu Y, Wang A, Lu Y. Inducing vascular normalization: A promising strategy for immunotherapy. Int Immunopharmacol 2022;112:109167. [PMID: 36037653 DOI: 10.1016/j.intimp.2022.109167] [Reference Citation Analysis]
33 Corbett V, Hallenbeck P, Rychahou P, Chauhan A. Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics. Front Mol Biosci 2022;9:930207. [DOI: 10.3389/fmolb.2022.930207] [Reference Citation Analysis]
34 Pang H, Lei D, Guo Y, Yu Y, Liu T, Liu Y, Chen T, Fan C. Three categories of similarities between the placenta and cancer that can aid cancer treatment: Cells, the microenvironment, and metabolites. Front Oncol 2022;12:977618. [DOI: 10.3389/fonc.2022.977618] [Reference Citation Analysis]
35 Ileiwat ZE, Tabish TA, Zinovkin DA, Yuzugulen J, Arghiani N, Pranjol MZI. The mechanistic immunosuppressive role of the tumour vasculature and potential nanoparticle-mediated therapeutic strategies. Front Immunol 2022;13:976677. [DOI: 10.3389/fimmu.2022.976677] [Reference Citation Analysis]
36 Sia CS, Lim HP, Tey BT, Goh BH, Low LE. Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment. Biochim Biophys Acta Rev Cancer 2022;1877:188779. [PMID: 35977690 DOI: 10.1016/j.bbcan.2022.188779] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Hu H, Ma T, Liu N, Hong H, Yu L, Lyu D, Meng X, Wang B, Jiang X. Immunotherapy checkpoints in ovarian cancer vasculogenic mimicry: Tumor immune microenvironments, and drugs. Int Immunopharmacol 2022;111:109116. [PMID: 35969899 DOI: 10.1016/j.intimp.2022.109116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Shi Y, Shang J, Li Y, Zhong D, Zhang Z, Yang Q, Lai C, Feng T, Yao Y, Huang X. ITGA5 and ITGB1 contribute to Sorafenib resistance by promoting vasculogenic mimicry formation in hepatocellular carcinoma. Cancer Med 2022. [PMID: 35946175 DOI: 10.1002/cam4.5110] [Reference Citation Analysis]
39 Bhattacharya S. Metabolic Reprogramming and Cancer: 2022. Qeios 2022. [DOI: 10.32388/ck9vjb.2] [Reference Citation Analysis]
40 bhattacharya S. Metabolic Reprogramming and Cancer: 2022.. [DOI: 10.32388/ck9vjb] [Reference Citation Analysis]
41 Yang X, Liang M, Yu Z, Fan J, Zheng M. A New Hypoxia-Related Prognostic Risk Score (HPRS) Model Was Developed to Indicate Prognosis and Response to Immunotherapy for Lung Adenocarcinoma. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/6373226] [Reference Citation Analysis]
42 Senchukova MA. Origen, morfología y significancia clínica de microvesículas de tumor en cáncer gástrico. Magna Sci UCEVA 2022;2:5-25. [DOI: 10.54502/msuceva.v2n1a2] [Reference Citation Analysis]
43 Hadizadeh M, AminJafari A, Parvizpour S, Ghasemi S. Novel targets to overcome antiangiogenesis therapy resistance in glioblastoma multiforme: Systems biology approach and suggestion of therapy by galunisertib. Cell Biol Int 2022. [PMID: 35842773 DOI: 10.1002/cbin.11859] [Reference Citation Analysis]
44 Chen Y, Tang M, Xiong J, Gao Q, Cao W, Huang J. GRB10 is a novel oncogene associated with cell proliferation and prognosis in glioma. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02636-5] [Reference Citation Analysis]
45 Huang M, Lin Y, Wang C, Deng L, Chen M, Assaraf YG, Chen ZS, Ye W, Zhang D. New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects. Drug Resist Updat 2022;64:100849. [PMID: 35842983 DOI: 10.1016/j.drup.2022.100849] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Shamshiripour P, Hajiahmadi F, Lotfi S, Esmaeili NR, Zare A, Akbarpour M, Ahmadvand D. Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside. Front Immunol 2022;13:859633. [PMID: 35757736 DOI: 10.3389/fimmu.2022.859633] [Reference Citation Analysis]
47 Chen Q, Li J, Shen P, Yuan H, Yin J, Ge W, Wang W, Chen G, Yang T, Xiao B, Miao Y, Lu Z, Wu P, Jiang K. Biological functions, mechanisms, and clinical significance of circular RNA in pancreatic cancer: a promising rising star. Cell Biosci 2022;12:97. [PMID: 35729650 DOI: 10.1186/s13578-022-00833-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Liu Y, Xu X, Zhang Y, Mo Y, Sun X, Shu L, Ke Y. Paradoxical role of β8 integrin on angiogenesis and vasculogenic mimicry in glioblastoma. Cell Death Dis 2022;13:536. [PMID: 35676251 DOI: 10.1038/s41419-022-04959-7] [Reference Citation Analysis]
49 Takao T, Masuda H, Kajitani T, Miki F, Miyazaki K, Yoshimasa Y, Katakura S, Tomisato S, Uchida S, Uchida H, Tanaka M, Maruyama T. Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway. Stem Cell Res Ther 2022;13:225. [PMID: 35659728 DOI: 10.1186/s13287-022-02888-y] [Reference Citation Analysis]
50 Contreras-sanzón E, Palma-flores C, Flores-pérez A, M. Salinas-vera Y, B. Silva-cázares M, A. Marchat L, G. Avila-bonilla R, N. Hernández de la Cruz O, E. Álvarez-sánchez M, Pérez-plasencia C, D. Campos-parra A, López-camarillo C. MicroRNA-204/CREB5 axis regulates vasculogenic mimicry in breast cancer cells. CBM 2022. [DOI: 10.3233/cbm-210457] [Reference Citation Analysis]
51 Liu X, He H, Zhang F, Hu X, Bi F, Li K, Yu H, Zhao Y, Teng X, Li J, Wang L, Zhang Y, Wu Q. m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling. Cell Death Dis 2022;13:483. [PMID: 35595748 DOI: 10.1038/s41419-022-04950-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
52 Eskandari E, Eaves CJ. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis. J Cell Biol 2022;221:e202201159. [PMID: 35551578 DOI: 10.1083/jcb.202201159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Jiao Y, Gao Y, Wang J, An H, Xiang Li Y, Zhang X. Intelligent porphyrin nano-delivery system for photostimulated and targeted inhibition of angiogenesis. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Liu Q, Zhao E, Geng B, Gao S, Yu H, He X, Li X, Dong G, You B. Tumor-associated macrophage-derived exosomes transmitting miR-193a-5p promote the progression of renal cell carcinoma via TIMP2-dependent vasculogenic mimicry. Cell Death Dis 2022;13:382. [PMID: 35443741 DOI: 10.1038/s41419-022-04814-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Souza JC, Bastos VC, Pereira NB, Dias AAM, Avelar GF, Gomez RS, Gomes CC. Angiogenesis in patient-derived xenografts of odontogenic myxoma. Int J Exp Pathol 2022. [PMID: 35225401 DOI: 10.1111/iep.12431] [Reference Citation Analysis]
56 Li J, Zhang G, Liu CG, Xiang X, Le MTN, Sethi G, Wang L, Goh BC, Ma Z. The potential role of exosomal circRNAs in the tumor microenvironment: insights into cancer diagnosis and therapy. Theranostics 2022;12:87-104. [PMID: 34987636 DOI: 10.7150/thno.64096] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 20.0] [Reference Citation Analysis]
57 Marques dos Reis E, Vieira Berti F. Vasculogenic Mimicry—An Overview. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2403-6_1] [Reference Citation Analysis]
58 Zhang L, Wu H, Zhang Y, Xiao X, Chu F, Zhang L. Induction of lncRNA NORAD accounts for hypoxia-induced chemoresistance and vasculogenic mimicry in colorectal cancer by sponging the miR-495-3p/ hypoxia-inducible factor-1α (HIF-1α). Bioengineered 2022;13:950-62. [PMID: 34969360 DOI: 10.1080/21655979.2021.2015530] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Filippi L, Pini A, Cammalleri M, Bagnoli P, Dal Monte M. β3-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: Suggestive clues from embryo. Med Res Rev 2021. [PMID: 34967048 DOI: 10.1002/med.21874] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Senchukova MA. Issues of origin, morphology and clinical significance of tumor microvessels in gastric cancer. World J Gastroenterol 2021;27:8262-82. [PMID: 35068869 DOI: 10.3748/wjg.v27.i48.8262] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Loap P, Vischioni B, Bonora M, Ingargiola R, Ronchi S, Vitolo V, Barcellini A, Goanta L, De Marzi L, Dendale R, Pacelli R, Locati L, Calugaru V, Mammar H, Cavalieri S, Kirova Y, Orlandi E. Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review. Front Oncol 2021;11:789079. [PMID: 34917512 DOI: 10.3389/fonc.2021.789079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Shimizu S, Kawahara R, Simizu S. Methionine aminopeptidase‑2 is a pivotal regulator of vasculogenic mimicry. Oncol Rep 2022;47:31. [PMID: 34913067 DOI: 10.3892/or.2021.8242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
63 Luo J, Sun P, Zhang X, Lin G, Xin Q, Niu Y, Chen Y, Xu N, Zhang Y, Xie W. Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway. Int J Mol Sci 2021;22:13336. [PMID: 34948132 DOI: 10.3390/ijms222413336] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 Cocola C, Magnaghi V, Abeni E, Pelucchi P, Martino V, Vilardo L, Piscitelli E, Consiglio A, Grillo G, Mosca E, Gualtierotti R, Mazzaccaro D, La Sala G, Di Pietro C, Palizban M, Liuni S, DePedro G, Morara S, Nano G, Kehler J, Greve B, Noghero A, Marazziti D, Bussolino F, Bellipanni G, D'Agnano I, Götte M, Zucchi I, Reinbold R. Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy. Front Cell Neurosci 2021;15:703431. [PMID: 34867197 DOI: 10.3389/fncel.2021.703431] [Reference Citation Analysis]
65 Song X, An Y, Chen D, Zhang W, Wu X, Li C, Wang S, Dong W, Wang B, Liu T, Zhong W, Sun T, Cao H. Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis. Cancer Sci 2021. [PMID: 34811848 DOI: 10.1111/cas.15208] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
66 Wang Y, Chen T, Li K, Mu W, Liu Z, Shi A, Liu J, Zhao W, Lian S, Huang S, Pan C, Zhang Z. Recent Advances in the Mechanism Research and Clinical Treatment of Anti-Angiogenesis in Biliary Tract Cancer. Front Oncol 2021;11:777617. [PMID: 34778094 DOI: 10.3389/fonc.2021.777617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
67 Hussen BM, Abdullah ST, Rasul MF, Salihi A, Ghafouri-Fard S, Hidayat HJ, Taheri M. MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets. Front Mol Biosci 2021;8:764025. [PMID: 34778378 DOI: 10.3389/fmolb.2021.764025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
68 Jiang X, Deng X, Wang J, Mo Y, Shi L, Wei F, Zhang S, Gong Z, He Y, Xiong F, Wang Y, Guo C, Xiang B, Zhou M, Liao Q, Li X, Li Y, Li G, Xiong W, Zeng Z. BPIFB1 inhibits vasculogenic mimicry via downregulation of GLUT1-mediated H3K27 acetylation in nasopharyngeal carcinoma. Oncogene 2021. [PMID: 34725462 DOI: 10.1038/s41388-021-02079-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
69 Shin SU, Cho HM, Das R, Gil-Henn H, Ramakrishnan S, Al Bayati A, Carroll SF, Zhang Y, Sankar AP, Elledge C, Pimentel A, Blonska M, Rosenblatt JD. Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases. Cells 2021;10:2904. [PMID: 34831127 DOI: 10.3390/cells10112904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
70 Massimini M, Romanucci M, De Maria R, Della Salda L. An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology. Front Vet Sci 2021;8:722432. [PMID: 34631854 DOI: 10.3389/fvets.2021.722432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 He W, Yang G, Liu S, Maghsoudloo M, Shasaltaneh MD, Kaboli PJ, Zhang C, Zhang J, Entezari M, Imani S, Wen Q. Comparative mRNA/micro-RNA co-expression network drives melanomagenesis by promoting epithelial-mesenchymal transition and vasculogenic mimicry signaling. Transl Oncol 2021;14:101237. [PMID: 34626953 DOI: 10.1016/j.tranon.2021.101237] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
72 Peri S, Biagioni A, Versienti G, Andreucci E, Staderini F, Barbato G, Giovannelli L, Coratti F, Schiavone N, Cianchi F, Papucci L, Magnelli L. Enhanced Vasculogenic Capacity Induced by 5-Fluorouracil Chemoresistance in a Gastric Cancer Cell Line. Int J Mol Sci 2021;22:7698. [PMID: 34299320 DOI: 10.3390/ijms22147698] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
73 Thankamony AP, Subbalakshmi AR, Jolly MK, Nair R. Lineage Plasticity in Cancer: The Tale of a Skin-Walker. Cancers (Basel) 2021;13:3602. [PMID: 34298815 DOI: 10.3390/cancers13143602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
74 Morales-Guadarrama G, García-Becerra R, Méndez-Pérez EA, García-Quiroz J, Avila E, Díaz L. Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers. Cells 2021;10:1758. [PMID: 34359928 DOI: 10.3390/cells10071758] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
75 Li L, Xiong F, Wang Y, Zhang S, Gong Z, Li X, He Y, Shi L, Wang F, Liao Q, Xiang B, Zhou M, Li X, Li Y, Li G, Zeng Z, Xiong W, Guo C. What are the applications of single-cell RNA sequencing in cancer research: a systematic review. J Exp Clin Cancer Res 2021;40:163. [PMID: 33975628 DOI: 10.1186/s13046-021-01955-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
76 Tan F, Zhao M, Xiong F, Wang Y, Zhang S, Gong Z, Li X, He Y, Shi L, Wang F, Xiang B, Zhou M, Li X, Li Y, Li G, Zeng Z, Xiong W, Guo C. N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies. J Exp Clin Cancer Res 2021;40:146. [PMID: 33926508 DOI: 10.1186/s13046-021-01952-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
77 Wang Y, Mo Y, Peng M, Zhang S, Gong Z, Yan Q, Tang Y, He Y, Liao Q, Li X, Wu X, Xiang B, Zhou M, Li Y, Li G, Li X, Zeng Z, Guo C, Xiong W. The influence of circular RNAs on autophagy and disease progression. Autophagy 2021;:1-14. [PMID: 33904341 DOI: 10.1080/15548627.2021.1917131] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
78 Obermann WMJ, Brockhaus K, Eble JA. Platelets, Constant and Cooperative Companions of Sessile and Disseminating Tumor Cells, Crucially Contribute to the Tumor Microenvironment. Front Cell Dev Biol 2021;9:674553. [PMID: 33937274 DOI: 10.3389/fcell.2021.674553] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
79 Delprat V, Michiels C. A bi-directional dialog between vascular cells and monocytes/macrophages regulates tumor progression. Cancer Metastasis Rev 2021;40:477-500. [PMID: 33783686 DOI: 10.1007/s10555-021-09958-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
80 van Noorden CJF, Hira VVV, van Dijck AJ, Novak M, Breznik B, Molenaar RJ. Energy Metabolism in IDH1 Wild-Type and IDH1-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy? Cells 2021;10:705. [PMID: 33810170 DOI: 10.3390/cells10030705] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
81 Zhang Y, Wang D, Peng M, Tang L, Ouyang J, Xiong F, Guo C, Tang Y, Zhou Y, Liao Q, Wu X, Wang H, Yu J, Li Y, Li X, Li G, Zeng Z, Tan Y, Xiong W. Single-cell RNA sequencing in cancer research. J Exp Clin Cancer Res 2021;40:81. [PMID: 33648534 DOI: 10.1186/s13046-021-01874-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 18.0] [Reference Citation Analysis]